Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11946044 Methods for isolating cell-free DNA

Patent 11946044 was granted and assigned to Guardant Health on April, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Guardant Health
Guardant Health
0
Date Filed
July 29, 2021
0
Date of Patent
April 2, 2024
0
Patent Applicant
Guardant Health
Guardant Health
0
Patent Application Number
17389199
0
Patent Citations
‌
US Patent 7282337 Methods for increasing accuracy of nucleic acid sequencing
0
‌
US Patent 7302146 Apparatus and method for analysis of molecules
0
‌
US Patent 7313308 Optical analysis of molecules
0
‌
US Patent 7329492 Methods for real-time single molecule sequence determination
0
‌
US Patent 7476503 Apparatus and method for performing nucleic acid analysis
0
‌
US Patent 7482120 Methods and compositions for improving fidelity in a nucleic acid synthesis reaction
0
‌
US Patent 7501245 Methods and apparatuses for analyzing polynucleotide sequences
0
‌
US Patent 9598731 Systems and methods to detect rare mutations and copy number variation
0
‌
US Patent 8486630 Methods for accurate sequence data and modified base position determination
0
‌
US Patent 6911345 Methods and apparatus for analyzing polynucleotide sequences
0
•••
Patent Inventor Names
Peter Vilem Grauman
0
Charbel Said Eid
0
Yupeng He
0
Ariel Jaimovich
0
Haley Dara Axelrod
0
Sven Jeffrey Duenwald
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11946044
0
Patent Primary Examiner
‌
Aaron A Priest
0
CPC Code
‌
C12Q 2600/156
0
‌
C12Q 2600/154
0
‌
C12Q 1/6886
0
‌
C12N 15/1065
0

Find more entities like US Patent 11946044 Methods for isolating cell-free DNA

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.